French CMO Yposkesi owned by SK builds 2nd plant to extend capacity
이 글자크기로 변경됩니다.
(예시) 가장 빠른 뉴스가 있고 다양한 정보, 쌍방향 소통이 숨쉬는 다음뉴스를 만나보세요. 다음뉴스는 국내외 주요이슈와 실시간 속보, 문화생활 및 다양한 분야의 뉴스를 입체적으로 전달하고 있습니다.
SK, the investment-specialized holding entity of South Korea¡¯s third largest conglomerate SK Group, said Monday that Yposkesi broke ground for its second factory that would cost 58 million euros ($70 million). The plant will be located in Genopole, the biggest biocluster in France where the company¡¯s first plant is located.
The new plant will command a 5,000-square-meter area, boosting the combined size of the two production facilities to 10,000 square meters when it is completed by 2023. It will become the largest CMO of cell and gene therapy for rare diseases in Europe.
SK bought a 70 percent stake in the French biologic CMO in April to tap deeper into the global biopharmaceutical market.
Gene and cell therapy aims to treat rare diseases by cultivating and modifying cells outside the body and injecting them into the patients. The advancement of the therapy is raising hope for the precision and personalized medicines for patients with rare diseases.
Market researchers including Deloitte estimate the gene and cell therapy market would reach $62 billion in 2025, growing 15 times from 2019. About half of new drugs under clinical trials in the United States and Europe are also gene and cell therapy products. The market barrier is especially high as it requires very advanced technology and expertise.
Yposkesi owns a gene vector production platform, which is at the center of the gene and cell therapy research and development. A vector is a gene transporter that injects treatment DNA into a virus and the body.
The new factory is designed to comply with Good Manufacturing Practices (GMP), the regulations enforced by the U.S. Food and Drug Administration (FDA). The first plant is also in compliance with GMP guidelines. The second factory will be equipped with large-scale bioreactors and refining system, ingredients manufacturing facility and quality control center to enable mass production.
[¨Ï Maeil Business Newspaper & mk.co.kr, All rights reserved]
Copyright © 매일경제 & mk.co.kr. 무단 전재, 재배포 및 AI학습 이용 금지
- Hyundai Mobis mulls collaborating with local foundries to make auto chips - Pulse by Maeil Business News Korea
- Japan launches anti-dumping probe on steel products from Korea - Pulse by Maeil Business News Korea
- Kanglim-Ssang Bang Wool challenges stalking horse bidder over Easter Jet - Pulse by Maeil Business News Korea
- Kakao to merge with Kakaocommerce to take on Naver, Coupang in e-commerce - Pulse by Maeil Business News Korea
- Hyundai Engineering bags $90 mn gas processing plant deal in Russia - Pulse by Maeil Business News Korea
- 강경준, 상간남 피소…사랑꾼 이미지 타격 [MK픽] - 스타투데이
- 정윤식 ING자산운용 상무 "원유시추선 관련주 주목"
- 하니, ‘10살 연상’ ♥양재웅과 결혼 발표 “함께하고 싶은 사람 만나”...EXID 첫 유부녀 탄생 - M
- 이찬원, 이태원 참사에 "노래 못해요" 했다가 봉변 당했다 - 스타투데이
- 양희은·양희경 자매, 오늘(4일) 모친상 - 스타투데이